ProBio Enters Exclusive Global Licensing Agreement with AbTis to Develop Next-Generation ADC Asset
· prnewswire.com · popularity 16/100 · 0 similar stories today · International Relations & World Affairs (Politics & Government)
Read the original at prnewswire.com →
Summary
Agreement expands collaboration between ProBio's biologics discovery capabilities and AbTis' site-specific antibody-drug conjugate technology HOPEWELL, N.J., Nov. 10, 2026 /PRNewswire/ -- ProBio, a global contract research, development, and manufacturing organization (CRDMO), today...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 17.